{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:06:18Z","timestamp":1791957978014,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbr.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T21:47:12Z","timestamp":1509832032000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effect of single doses of pindolol and d-fenfluramine on flumazenil-induced anxiety in panic disorder patients"],"prefix":"10.1016","volume":"357-358","author":[{"given":"M.","family":"Bernik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.T.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.B.","family":"Hetem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Graeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2017.11.002_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10253890500492787","article-title":"Modulation of anxiety circuits by serotonergic systems","volume":"8","author":"Lowry","year":"2005","journal-title":"Stress"},{"key":"10.1016\/j.bbr.2017.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300880","article-title":"Serotonin function in panic disorder: important, but why?","volume":"31","author":"E.Maron","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.11.002_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","article-title":"Role of 5-HT in stress, anxiety and depression","volume":"54","author":"Graeff","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2017.11.002_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0030","series-title":"Textbook of Biological Psychiatry","first-page":"879","article-title":"Animal models of anxiety disorders","author":"Graeff","year":"2002"},{"key":"10.1016\/j.bbr.2017.11.002_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2004.03.005","article-title":"A two-dimensional neuropsychology of defense: fear\/anxiety and defensive distance","volume":"28","author":"Mc Naughtoon","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2017.11.002_bib0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2003.12.004","article-title":"The periacquedutal gray and panic","volume":"28","author":"Graeff Serotonin","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2017.11.002_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02246145","article-title":"Differential modulation of antipredator defensive behavior in swiss webster mice following acute and chronic administration of imipramine and fluoxetine","volume":"120","author":"Griebel","year":"1995","journal-title":"Psychopharmacology. (Berl)"},{"key":"10.1016\/j.bbr.2017.11.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/108135","article-title":"Panic disorder: is the PAG involved?","author":"Del-Ben","year":"2009","journal-title":"Neural Plast."},{"key":"10.1016\/j.bbr.2017.11.002_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0149-7634(98)00024-4","article-title":"The elevated T maze as an experimental model of anxiety","volume":"23","author":"Graeff","year":"1998","journal-title":"Neurosc Biobehav. Rev."},{"key":"10.1016\/j.bbr.2017.11.002_bib0060","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00213-005-0196-z","article-title":"5HT-1A and 5-HT2A receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of seronergic neurons in the dorsal raphe nucleus","volume":"183","author":"Pobbe","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.11.002_bib0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euroneuro.2010.05.004","article-title":"Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors","volume":"21","author":"Pobbe","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/0269881115590603","article-title":"Evidence for serotonin function as a neurochemical difference between fear and anxiety disorders in humans","volume":"29","author":"Corchs","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0361-9230(87)90106-7","article-title":"Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor","volume":"19","author":"Little","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2017.11.002_bib0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1192\/bjp.160.2.165","article-title":"Panic attacks: a neurochemical overview of models and mechanisms","volume":"160","author":"Nutt","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.11.002_bib0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.1990.01810220033004","article-title":"Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in PD","volume":"47","author":"Nutt","year":"1990","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.bbr.2017.11.002_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(91)90124-8","article-title":"Behavioural, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in PD","volume":"36","author":"Woods","year":"1991","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.bbr.2017.11.002_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/026988119100500306","article-title":"Flumazenil precipitated withdrawal in chronic users of low doses of diazepam","volume":"5","author":"Bernik","year":"1991","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/026988119801200205","article-title":"Stressfull reactions and panic attacks induced by flumazenil in chronic benzodiazepine users","author":"Bernik","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hup.470040105","article-title":"Saturation analysis of specific 11C Ro 15-1788 binding to the human neocortex using positron emission tomography","volume":"4","author":"Persson","year":"1989","journal-title":"Human Psychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1471-4159.2000.0750755.x","article-title":"Affinity of (+\/\u2212)-pindolol, (\u2212)-penbutolol, and (\u2212)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain","volume":"75","author":"Castro","year":"2000","journal-title":"Neurochem"},{"key":"10.1016\/j.bbr.2017.11.002_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0893-133X(00)00187-1","article-title":"Differential occupancy of somatodendritic and postsynaptic 5HT1. A receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans","volume":"24","author":"Martinez","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.11.002_bib0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02527753","article-title":"Enhacement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (\u2212)-pindolol, an antagonist at 5-HT1A receptors","volume":"21","author":"Dreshfield","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2017.11.002_bib0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s002130051009","article-title":"Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography","volume":"144","author":"Andree","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.11.002_bib0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<68::AID-SYN8>3.0.CO;2-Z","article-title":"Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (\u2212)pindolol. A comparative study in rodent primate and human brain","volume":"34","author":"Raurich","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2017.11.002_bib0135","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00003495-199243050-00007","article-title":"Dexfenfluramine: a review of its pharmacological properties and therapeutic potential in obesity","volume":"43","author":"Mc Tavish","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2017.11.002_bib0140","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1046\/j.1471-4159.1994.63031163.x","article-title":"Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism","volume":"63","author":"Bonano","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2017.11.002_bib0145","first-page":"639","article-title":"D-Fenfluramine selectively releases 5-HT from dorsal raphe terminals","volume":"29","author":"Viana","year":"1996","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbr.2017.11.002_bib0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.2042-7158.1972.tb08942.x","article-title":"Pharmacokinetics of absorption: distribution and elimination of fenfluramine and its main metabolite in man","volume":"24","author":"Beckett","year":"1972","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0155","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/00498258909042294","article-title":"The measurement of D-Fenfluramine and its metabolite, D-Norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies","volume":"19","author":"Richards","year":"1989","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbr.2017.11.002_bib0160","series-title":"Clinical Trials","article-title":"S. J. pocock","year":"1996"},{"key":"10.1016\/j.bbr.2017.11.002_bib0165","series-title":"Schedule for Affective Disorders and Schizophrenia \u2013life Time Version (SADS-L","author":"Spitzer","year":"1979"},{"key":"10.1016\/j.bbr.2017.11.002_bib0170","series-title":"American Psychiatric Association Diagnostic and Statistics Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.bbr.2017.11.002_bib0175","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.bbr.2017.11.002_bib0180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2017.11.002_bib0185","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.bbr.2017.11.002_bib0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for PD and agoraphobia: II: the panic and Agoraphobia Scale","volume":"10","author":"Bandelow","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/026988110201600116","article-title":"Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine","volume":"16","author":"Bell","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.11.002_bib0200","first-page":"1061","article-title":"Flumazenil, a reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist","volume":"42","author":"Broagden","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2017.11.002_bib0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0140-6736(91)90799-U","article-title":"Feasibility of reversing benzodiazepine tolerance with flumazenil","volume":"337","author":"Savic","year":"1991","journal-title":"Lancet"},{"issue":"S2","key":"10.1016\/j.bbr.2017.11.002_bib0210","doi-asserted-by":"crossref","first-page":"187S","DOI":"10.1111\/j.1365-2125.1982.tb01909.x","article-title":"Pindolol\u2013a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations","volume":"13","author":"Aellig","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbr.2017.11.002_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1192\/bjp.173.3.203","article-title":"Pindolol augmentation of antidepressant therapy","volume":"173","author":"McAskill","year":"1998","journal-title":"Brit. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.11.002_bib0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0976-500X.149144","article-title":"Pindolol augmentation of selective serotonin reuptke inhibitors and clomipamine for the treatment of obsessive-compulsive disorder: a meta-analysis","volume":"6","author":"Sassano-Higgins","year":"2015","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.bbr.2017.11.002_bib0225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF02806003","article-title":"Effect of d-fenfluramine on human experimental anxiety","volume":"127","author":"Hetem","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.11.002_bib0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-1781(89)90210-2","article-title":"Fenfluramine provocation of anxiety in patients with PD","volume":"28","author":"Targum","year":"1989","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.bbr.2017.11.002_bib0235","first-page":"603","article-title":"Panic, suffocation false alarms separation anxiety and endogenous opioids","author":"Klein","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.bbr.2017.11.002_bib0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neubiorev.2014.03.025","article-title":"Lifelong opioidergic vulnerability through early life separation: a recent extension of the false suffocation alarm theory of panic disorder","volume":"3","author":"Preter","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2017.11.002_bib0245","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrn3301","article-title":"The many paths to fear","volume":"13","author":"Gross","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2017.11.002_bib0250","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1590\/S0100-879X1997000700011","article-title":"Hormonal response during a fenfluramine-associated panic attack","volume":"30","author":"Vieira","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbr.2017.11.002_bib0255","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0006-3223(98)00295-9","article-title":"Behavioral, neuroendocrine, and cardiovascular response to flumazenil no evidence for an altered benzodiazepine receptor sensitivity in panic disorder","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.11.002_bib0260","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1176\/ajp.155.5.610","article-title":"Effect of flumazenil in lactate-sensitive patients with panic disorder","volume":"155","author":"Str\u00f6hle","year":"1998","journal-title":"Am. J. Psychiatry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817304539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817304539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T17:05:31Z","timestamp":1543943131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817304539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"alternative-id":["S0166432817304539"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.11.002","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of single doses of pindolol and d-fenfluramine on flumazenil-induced anxiety in panic disorder patients","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}